Survival in the United Kingdom Medical Research Council AML trials 1970–1999 for patients aged 15–59 years.
Relapse Myeloma
1 Copyright 2008 Genoptix, Inc. Mike Nerenberg, MD CTO & Sr. VP Business Development Genoptix, Inc. B.A. University of Chicago M.D. Yale University School.
